Cargando…
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
Pediatric Evans syndrome (pES) is increasingly identified as the presenting manifestation of several inborn errors of immunity. Despite an improved understanding of genetic defects in pES, the underlying immunobiology of pES is poorly defined, and characteristic diagnostic immune parameters are lack...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777200/ https://www.ncbi.nlm.nih.gov/pubmed/34424963 http://dx.doi.org/10.1182/blood.2021012924 |
_version_ | 1784637012904509440 |
---|---|
author | Kumar, Deepak Prince, Chengyu Bennett, Carolyn M. Briones, Michael Lucas, Laura Russell, Athena Patel, Kiran Chonat, Satheesh Graciaa, Sara Edington, Holly White, Michael H. Kobrynski, Lisa Abdalgani, Manar Parikh, Suhag Chandra, Sharat Bleesing, Jack Marsh, Rebecca Park, Sunita Waller, Edmund K. Prahalad, Sampath Chandrakasan, Shanmuganathan |
author_facet | Kumar, Deepak Prince, Chengyu Bennett, Carolyn M. Briones, Michael Lucas, Laura Russell, Athena Patel, Kiran Chonat, Satheesh Graciaa, Sara Edington, Holly White, Michael H. Kobrynski, Lisa Abdalgani, Manar Parikh, Suhag Chandra, Sharat Bleesing, Jack Marsh, Rebecca Park, Sunita Waller, Edmund K. Prahalad, Sampath Chandrakasan, Shanmuganathan |
author_sort | Kumar, Deepak |
collection | PubMed |
description | Pediatric Evans syndrome (pES) is increasingly identified as the presenting manifestation of several inborn errors of immunity. Despite an improved understanding of genetic defects in pES, the underlying immunobiology of pES is poorly defined, and characteristic diagnostic immune parameters are lacking. We describe the immune characteristics of 24 patients with pES and compared them with 22 patients with chronic immune thrombocytopenia (cITP) and 24 healthy controls (HCs). Compared with patients with cITP and HC, patients with pES had increased circulating T-follicular helper cells (cTfh), increased T-cell activation, and decreased naïve CD4(+) T cells for age. Despite normal or high immunoglobulin G (IgG) in most pES at presentation, class-switched memory B cells were decreased. Within the cTfh subset, we noted features of postactivation exhaustion with upregulation of several canonical checkpoint inhibitors. T-cell receptor β chain (TCR-β) repertoire analysis of cTfh cells revealed increased oligoclonality in patients with pES compared with HCs. Among patients with pES, those without a known gene defect had a similar characteristic immune abnormality as patients with defined genetic defects. Similarly, patients with pES with normal IgG had similar T-cell abnormalities as patients with low IgG. Because genetic defects have been identified in less than half of patients with pES, our findings of similar immune abnormalities across all patients with pES help establish a common characteristic immunopathology in pES, irrespective of the underlying genetic etiology. |
format | Online Article Text |
id | pubmed-8777200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-87772002022-03-03 T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome Kumar, Deepak Prince, Chengyu Bennett, Carolyn M. Briones, Michael Lucas, Laura Russell, Athena Patel, Kiran Chonat, Satheesh Graciaa, Sara Edington, Holly White, Michael H. Kobrynski, Lisa Abdalgani, Manar Parikh, Suhag Chandra, Sharat Bleesing, Jack Marsh, Rebecca Park, Sunita Waller, Edmund K. Prahalad, Sampath Chandrakasan, Shanmuganathan Blood Immunobiology and Immunotherapy Pediatric Evans syndrome (pES) is increasingly identified as the presenting manifestation of several inborn errors of immunity. Despite an improved understanding of genetic defects in pES, the underlying immunobiology of pES is poorly defined, and characteristic diagnostic immune parameters are lacking. We describe the immune characteristics of 24 patients with pES and compared them with 22 patients with chronic immune thrombocytopenia (cITP) and 24 healthy controls (HCs). Compared with patients with cITP and HC, patients with pES had increased circulating T-follicular helper cells (cTfh), increased T-cell activation, and decreased naïve CD4(+) T cells for age. Despite normal or high immunoglobulin G (IgG) in most pES at presentation, class-switched memory B cells were decreased. Within the cTfh subset, we noted features of postactivation exhaustion with upregulation of several canonical checkpoint inhibitors. T-cell receptor β chain (TCR-β) repertoire analysis of cTfh cells revealed increased oligoclonality in patients with pES compared with HCs. Among patients with pES, those without a known gene defect had a similar characteristic immune abnormality as patients with defined genetic defects. Similarly, patients with pES with normal IgG had similar T-cell abnormalities as patients with low IgG. Because genetic defects have been identified in less than half of patients with pES, our findings of similar immune abnormalities across all patients with pES help establish a common characteristic immunopathology in pES, irrespective of the underlying genetic etiology. American Society of Hematology 2022-01-20 /pmc/articles/PMC8777200/ /pubmed/34424963 http://dx.doi.org/10.1182/blood.2021012924 Text en © 2022 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Immunobiology and Immunotherapy Kumar, Deepak Prince, Chengyu Bennett, Carolyn M. Briones, Michael Lucas, Laura Russell, Athena Patel, Kiran Chonat, Satheesh Graciaa, Sara Edington, Holly White, Michael H. Kobrynski, Lisa Abdalgani, Manar Parikh, Suhag Chandra, Sharat Bleesing, Jack Marsh, Rebecca Park, Sunita Waller, Edmund K. Prahalad, Sampath Chandrakasan, Shanmuganathan T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome |
title | T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome |
title_full | T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome |
title_fullStr | T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome |
title_full_unstemmed | T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome |
title_short | T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome |
title_sort | t-follicular helper cell expansion and chronic t-cell activation are characteristic immune anomalies in evans syndrome |
topic | Immunobiology and Immunotherapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777200/ https://www.ncbi.nlm.nih.gov/pubmed/34424963 http://dx.doi.org/10.1182/blood.2021012924 |
work_keys_str_mv | AT kumardeepak tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT princechengyu tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT bennettcarolynm tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT brionesmichael tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT lucaslaura tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT russellathena tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT patelkiran tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT chonatsatheesh tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT graciaasara tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT edingtonholly tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT whitemichaelh tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT kobrynskilisa tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT abdalganimanar tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT parikhsuhag tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT chandrasharat tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT bleesingjack tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT marshrebecca tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT parksunita tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT walleredmundk tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT prahaladsampath tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome AT chandrakasanshanmuganathan tfollicularhelpercellexpansionandchronictcellactivationarecharacteristicimmuneanomaliesinevanssyndrome |